|Articles|February 12, 2015
Rite Aid Sees Advantage in Buying an Established PBM
The New York Times reported today that the drug store chain Rite Aid will buy Envision Pharmaceutical Services, a pharmacy benefit manager, for $2 billion.
Advertisement
Rite Aid, the big pharmacy chain, agreed on Wednesday to acquire a top pharmacy benefit manager, Envision Pharmaceutical Services, for $2 billion in cash and stock .
Envision Pharmaceutical Services, known as EnvisionRx, is owned by the private equity firm TPG, making this one of the year’s early successful exits for a buyout firm.
Rite Aid will pay TPG about $1.8 billion in cash and $200 million in stock for EnvisionRx. The value of the deal also includes an expected future tax benefit of $275 million.
Complete report on The New York Times:
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug
2
New York Experts Push for Coordinated Obesity Care Teams
3
Grocery Assistance Benefit Linked to Fewer Diabetes Complications
4
FDA Clears First Single-Biomarker Blood Test for Alzheimer
5